See the DrugPatentWatch profile for aspirin

Aspirin and Vascepa are medications that can affect blood clotting differently. Aspirin is an antiplatelet drug, which means it works by preventing platelets in your blood from sticking together to form clots [1]. It is commonly used to reduce the risk of heart attacks and strokes.

Vascepa, on the other hand, is a prescription medication that contains the active ingredient icosapent ethyl. It is used to lower triglyceride levels in adults with severe (500 mg/dL or higher) hypertriglyceridemia. Vascepa is a type of omega-3 acid, which is a fatty acid that may help reduce the risk of heart disease [2].

According to DrugPatentWatch.com, there are currently no patents listed for Vascepa in combination with aspirin [3]. However, it is important to note that taking both medications together could increase the risk of bleeding due to their effects on blood clotting.

A study published in the American Journal of Cardiology found that the combination of aspirin and omega-3 fatty acids (such as those found in Vascepa) may increase the risk of bleeding, particularly in the gastrointestinal tract [4]. Therefore, it is important to consult with a healthcare provider before taking both medications together.

In summary, while there is no current patent for the combination of aspirin and Vascepa, taking both medications together could increase the risk of bleeding due to their effects on blood clotting. It is important to consult with a healthcare provider before taking both medications together.

Sources:

1. Mayo Clinic. (2021). Aspirin: Uses, side effects, and dosing. <https://www.mayoclinic.org/drugs-supplements-aspirin/art-20365802>.
2. Vascepa (icosapent ethyl) capsules, for oral use. (2021). <https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206357s010lbl.pdf>.
3. DrugPatentWatch.com. (2022). Vascepa. <https://www.drugpatentwatch.com/drugs/vascepa>.
4. McLaughlin, T., & Weber, C. (2013). Aspirin and omega-3 fatty acids: A new combination for cardiovascular protection? American Journal of Cardiology, 111(1), 1-3. <https://www.sciencedirect.com/science/article/abs/pii/S000291491202220X>.